We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
CDT

Price
18.40
Stock movement down
-0.08 (-0.65%)
Company name
Conduit Pharmaceuticals Inc.
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Biotechnology
Market cap
4.70M
Ent value
-
Price/Sales
-
Price/Book
-
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-
1 year return
-99.35%
3 year return
-95.33%
5 year return
-
10 year return
-
Last updated: 2025-09-12

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

DIVIDENDS

CDT does not pay dividends or no data was received

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales-
Price to Book-
EV to Sales-

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

FINANCIALS

iO Charts is a Seeking Alpha partner

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open12.40
Daily high12.40
Daily low12.12
Daily Volume3K
All-time high203880.00
1y analyst estimate-
Beta1.91
EPS (TTM)-
Dividend per share-
Ex-div date-
Next earnings date12 Nov 2025

Downside potential

Loading...
Downside potential data
CDTS&P500
Current price drop from All-time high-99.99%-1.46%
Highest price drop-99.99%-56.47%
Date of highest drop21 Aug 20259 Mar 2009
Avg drop from high-52.03%-10.99%
Avg time to new high11 days12 days
Max time to new high481 days1805 days

iO Charts is a Seeking Alpha partner

COMPANY DETAILS
CDT (Conduit Pharmaceuticals Inc.) company logo
Marketcap
4.70M
Marketcap category
Small-cap
Description
CDT Equity Inc., a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility. It has strategic services agreement with formulation development CDMO Agility Life Sciences to develop new solid oral-dosage form products. The company was formerly known as Conduit Pharmaceuticals Inc. and changed its name to CDT Equity Inc. in August 2025. The company was founded in 2019 and is based in Naples, Florida.
Employees
6
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

UNDERSTAND THE BUSINESS
Loading...